In vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents Against Human Mycoplasmas and Ureaplasmas Including Isolates with Defined Resistance Mechanisms release_6umlvrlakzhohmoj2tttbhuxpi

by G. Xue, D.M. Crabb, L. Xiao, Y. Liu, K.B. Waites

Published in Antimicrobial Agents and Chemotherapy by American Society for Microbiology.

2018   AAC.01348-18

Abstract

Levonadifloxacin (WCK 771) was evaluated against 68 type strains and clinical isolates of <jats:italic>Mycoplasma genitalium</jats:italic>, <jats:italic>Mycoplasma hominis</jats:italic>, <jats:italic>Mycoplasma pneumoniae</jats:italic> and <jats:italic>Ureaplasma</jats:italic> species in comparison to moxifloxacin, levofloxacin, tetracycline and azithromycin or clindamycin. Levonadifloxacin MICs were ≤ 0.5 μg/ml for <jats:italic>Mycoplasma genitalium.</jats:italic> MIC<jats:sub>90s</jats:sub> (μg/ml) were 1 (<jats:italic>Mycoplasma hominis</jats:italic>), 0.125 (<jats:italic>Mycoplasma pneumoniae</jats:italic>) and 2 (<jats:italic>Ureaplasma</jats:italic> spp). Levonadifloxacin merits further study for treating infections caused by these organisms.
In application/xml+jats format

Archived Files and Locations

application/pdf  157.9 kB
file_pwbkh7ztazhkvdvjzq4v2be66y
aac.asm.org (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2018-08-13
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0066-4804
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 0ad1becf-2fef-45ed-a346-976e91518379
API URL: JSON